Assessment of hepatitis C: Non-invasive fibrosis markers and/or liver biopsy

Liver International

Volumn 29, Issue SUPPL. 1, 2009, Pages 19-22

  Bedossa, Pierre ^a  

^a BEAUJON HOSPITAL   (France)

Author keywords

Fibrosis; Liver biopsy; Noninvasive markers

Indexed keywords

ANXIETY; BILIARY PERITONITIS; CONFERENCE PAPER; DISEASE MARKER; DISEASE SEVERITY; GENOTYPE; HEMOPERITONEUM; HEPATITIS C; HISTOPATHOLOGY; HUMAN; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER FIBROSIS; NON INVASIVE PROCEDURE; PAIN; PNEUMOTHORAX; PROGNOSIS; RIGIDITY; VIRUS HEPATITIS;

BIOLOGICAL MARKERS; BIOPSY; HEPATITIS C, CHRONIC; HUMANS; LIVER; LIVER CIRRHOSIS; PROGNOSIS;

EID: 59149088088     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2008.01940.x     Document Type: Conference Paper

References (26)

1. Yano M, Kumada H, Kage M, et al. The long-term pathological evolution of chronic hepatitis C. Hepatology 1996; 23: 1334-40.
2. Khan MH, Farrell GC, Byth K, et al. Which patients with hepatitis C develop liver complications? Hepatology 2000; 31: 513-20.
3. Poynard T, Ratziu V, Benhamou Y, et al. Natural history of HCV infection. Bailleres Clin Gastroenterol 2000; 14: 211-28.
4. Perrillo RP. The role of liver biopsy in hepatitis C. Hepatology 1997; 26(Suppl.): 57S-61S.
5. Cadranel JF, Rufat P, Degos F. Practices of liver biopsy in France: results of a prospective nationwide survey. For the Group of Epidemiology of the French Association for the Study of the Liver (AFEF). Hepatology 2000; 32: 477-81.
6. Piccinino F, Sagnelli E, Pasquale G, Giusti G. Complications following percutaneous liver biopsy a multicentre retrospective study on 68276 biopsies. J Hepatol 1986; 2: 165-73.
7. Myers RP, Fong A, Shaheen AA. Utilization rates, complications and costs of percutaneous liver biopsy: A population-based study including 4275 biopsies. Liver Int 2008; 28: 705-12.
8. Actis GC, Olivero A, Lagget M, et al. The practice of percutaneous liver biopsy in a gastrohepatology day hospital: A retrospective study on 835 biopsies. Dig Dis Sci 2007; 52: 2576-9.
9. Regev A, Berho M, Jeffers LJ, et al. Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection. Am J Gastroenterol 2002; 97: 2614-816.
10. Guido M, Rugge M. Liver biopsy sampling in chronic viral hepatitis. Semin Liver Dis 2004; 24: 89-97.
11. METAVIR cooperative group. Inter- and intra-observer variation in the assessment of liver biopsy of chronic hepatitis C. Hepatology 1994; 20: 15-20.
12. Bedossa P, Dargère D, Paradis V. Sampling variability of liver fibrosis in chronic hepatitis C. Hepatology 2003; 38: 1449-57.
13. Colloredo G, Guido M, Sonzogni Aleandro G. Impact of liver biopsy size on histological evaluation of chronic viral hepatitis: The smaller the sample, the milder the disease. J Hepatol 2003; 39: 239-44.
14. Westin J, Lagging LM, Wejstal R, et al. Interobserver study of liver histopathology using the Ishak score in patients with chronic hepatitis C virus infection. Liver 1999; 19: 183-7.
15. Goldin RD, Goldin JG, Burt AD, et al. Intra-observer and inter-observer variation in the histopathological assessment of chronic viral hepatitis. J Hepatol 1996; 25: 649-54.
16. Rousselet MC, Michalak S, Dupre F, et al. Sources of variability in histological scoring of chronic viral hepatitis. Hepatology 2005; 41: 257-64.
17. Ishak K, Baptista A, Bianchi L, et al. Histological grading and staging of chronic hepatitis. J Hepatol 1995; 22: 696-9.
18. Bedossa P. the METAVIR cooperative study group. An algorithm for the grading of activity in chronic hepatitis. Hepatology 1996; 24: 289-93.
19. Bedossa P, Moucari R, Chelbi E, et al. Evidence for a role of nonalcoholic steatohepatitis in hepatitis C: A prospective study. Hepatology 2007; 46: 380-7.
20. Manning DS, Afdhal NH. Diagnosis and quantitation of fibrosis. Gastroenterology 2008; 134: 1670-81.
21. Friedrich-Rust M, Ong MF, Martens S, et al. Performance of transient elastography for the staging of liver fibrosis: A meta-analysis. Gastroenterology 2008; 134: 960-74.
22. Poynard T, Morra R, Halfon P, et al. Meta-analyses of FibroTest diagnostic value in chronic liver disease. BMC Gastroenterol 2007; 7: 40.
23. Cales P, de Ledinghen V, Halfon P, et al. Evaluating the accuracy and increasing the reliable diagnosis rate of blood tests for liver fibrosis in chronic hepatitis C. Liver Int 2008; 5: 1352-62.
24. Standish RA, Cholongitas E, Dhillon A, Burroughs AK, Dhillon AP. An appraisal of the histopathological assessment of liver fibrosis. Gut 2006; 55: 569-78.
25. Masseroli M, Caballero T, O'valle F, et al. Automatic quantification of liver fibrosis: Design and validation of a new image analysis method: comparison with semi-quantitative indexes of fibrosis. J Hepatol 2000; 32: 453-64.
26. Dienstag JL, Mchutchison J. American gastroenterological association technical review on the management of hepatitis C. Gastroenterology 2006; 130: 231-64.